Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection

F Peracchi^{1

2}, M Merli¹, C Rogati¹, E Ravano³, M Puoti^{1

2}, R Cairoli^{2

3}, G Travi¹

Affiliations

¹ Division of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
² School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
³ Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

F Peracchi et al. Br J Haematol. 2023 Jun.

. 2023 Jun;201(6):e62-e65.

doi: 10.1111/bjh.18827. Epub 2023 Apr 21.

F Peracchi^{1

2}, M Merli¹, C Rogati¹, E Ravano³, M Puoti^{1

2}, R Cairoli^{2

3}, G Travi¹

¹ Division of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
² School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
³ Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

No abstract available

References

1. Gur I, Giladi A, Isenberg YN, Neuberger A, Stern A. COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response. Acta Haematol. 2022;145:297-309.
1. Naimi A, Yashmi I, Jebeleh R, Imani Mofrad M, Azimian Abhar S, Jannesar Y, et al. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: a systematic review and meta-analysis. J Clin Lab Anal. 2022;36:e24387.
1. Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European conference on infections in Leukaemia (ECIL 9). Leukemia. 2022;36:1467-80.
1. Dioverti V, Salto-Alejandre S, Haidar G. Immunocompromised patients with protracted COVID-19: a review of “long Persisters”. Curr Transplant Rep. 2022;9:209-218.
1. Carlin AF, Clark AE, Chaillon A, Garretson AF, Bray W, Porrachia M, et al. Virologic and immunologic characterization of coronavirus disease 2019 recrudescence after nirmatrelvir/ritonavir treatment. Clin Infect Dis. 2023;76:e530-e532.